temozolomide has been researched along with sitagliptin phosphate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, S; Hu, Z; Li, C; Meng, Q; Wang, Y; You, F; Yu, R; Zhang, Q; Zhang, S; Zhang, T | 1 |
1 other study(ies) available for temozolomide and sitagliptin phosphate
| Article | Year |
|---|---|
Sitagliptin inhibits the survival, stemness and autophagy of glioma cells, and enhances temozolomide cytotoxicity.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioblastoma; Glioma; Humans; Mice; Sitagliptin Phosphate; Temozolomide; Xenograft Model Antitumor Assays | 2023 |